BiotechTube

ASP7487, Velcade, Dexamethasone

Phase 1/2Terminated
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Multiple Myeloma

Conditions

Multiple Myeloma

Trial Timeline

Sep 1, 2012 → Dec 27, 2017

NCT ID
NCT01672736

About ASP7487, Velcade, Dexamethasone

ASP7487, Velcade, Dexamethasone is a phase 1/2 stage product being developed by Astellas Pharma for Multiple Myeloma. The current trial status is terminated. This product is registered under clinical trial identifier NCT01672736. Target conditions include Multiple Myeloma.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT01672736Phase 1/2Terminated

Competing Products

20 competing products in Multiple Myeloma

See all competitors
ProductCompanyStageHype Score
Placebo + PirtobrutinibEli LillyPhase 2
52
Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomideEli LillyPhase 1/2
41
NEX-20ANanexa ABPhase 1
28
agenT-797MiNK TherapeuticsPhase 1
25
Duloxetine Hydrochloride (HCI) + PlaceboEli LillyPhase 3
77
TemferonGenenta SciencePhase 1/2
33
CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab)CelltrionPhase 3
77
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
CS-0777 tablets + CS-0777 tablets + CS-0777 tabletsDaiichi SankyoPhase 1
33
PHE885NovartisPhase 2
52
Mirabegron + PlaceboAstellas PharmaApproved
85
Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + PlaceboAstellas PharmaApproved
85
Denileukin Diftitox (Ontak)EisaiPhase 1
33
PalonosetronEisaiPhase 2
52
BIW-8962Kyowa KirinPhase 1
33
KRN125(pegfilgrastim), PLR001(plerixafor) + KRN8601(filgrastim), PLR001(plerixafor)Kyowa KirinPhase 2
52
KW-2478 + BortezomibKyowa KirinPhase 1/2
41
ONO-2808 + PlaceboOno PharmaceuticalPhase 2
52
KW-2478Kyowa KirinPhase 1
33
ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placeboOno PharmaceuticalPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85